Answers are grounded in this paper and cite their sources.
Preprint of a theoretical Perspective. This manuscript proposes a conceptual framework and a prospective validation agenda; it does not report newly generated primary data. It has not been certified by peer review. Cancer biology has catalogued its parts in exquisite detail yet still lacks a coherent account of the whole: why identical driver mutations remain silent in one individual and ignite malignancy in another. We propose the trilateral circuit system (TICS) dysregulation-threshold theory, which couples metabolism, immunity and cellular repair into one physiological circuit. Carcinogenesis is licensed not by any single molecular event but by a system-level critical transition: when a quantifiable dysregulation index crosses an individual-specific threshold, the network loses the multistable regulatory landscape that enforces differentiation and restrains pre-malignant clones. Driver mutations, immunoediting, metabolic reprogramming and field cancerization are repositioned as subsystem-specific failure modes requiring a permissive system state for phenotypic execution, which resolves the mutations-in-normal-tissue paradox and recasts hereditary syndromes as constitutively lowered thresholds rather than deterministic fate. We specify the operational definition of the index, the statistical signature of threshold crossing, three falsifiable predictions with matched validation designs, and explicit refutation criteria. Prevention is thereby redirected from reactive tumour targeting toward proactive stabilization of the circuit: from hunting the mutational key to reinforcing the lock. The cancer genotype loads the gun, but only a dysregulated system pulls the trigger — and the trigger is measurable before it is pulled. Mingli He and Yanan He contributed equally. Corresponding author: Mingli He. Supplementary Figures 1 and 2 are included in Manuscript.pdf; supplementary tables and notes are in Supplementary_Information.pdf.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: